Logo image of OZ

BELPOINTE PREP LLC (OZ) Stock Fundamental Analysis

NYSEARCA:OZ - NYSE Arca - US0806941029 - Common Stock - Currency: USD

61.655  +0.41 (+0.66%)

Fundamental Rating

1

OZ gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of OZ have multiple concerns. OZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OZ had negative earnings in the past year.
In the past year OZ has reported a negative cash flow from operations.
In the past 5 years OZ always reported negative net income.
In the past 5 years OZ always reported negative operating cash flow.
OZ Yearly Net Income VS EBIT VS OCF VS FCFOZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of OZ (-4.61%) is comparable to the rest of the industry.
With a Return On Equity value of -7.90%, OZ perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -4.61%
ROE -7.9%
ROIC N/A
ROA(3y)-3.51%
ROA(5y)-2.35%
ROE(3y)-4.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OZ Yearly ROA, ROE, ROICOZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40 60 80 100

1.3 Margins

OZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OZ Yearly Profit, Operating, Gross MarginsOZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

OZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
OZ has more shares outstanding than it did 1 year ago.
The debt/assets ratio for OZ is higher compared to a year ago.
OZ Yearly Shares OutstandingOZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
OZ Yearly Total Debt VS Total AssetsOZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

A Debt/Equity ratio of 0.60 indicates that OZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, OZ is in line with its industry, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.49%
OZ Yearly LT Debt VS Equity VS FCFOZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

OZ has a Current Ratio of 0.88. This is a bad value and indicates that OZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.88, OZ is doing worse than 75.00% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that OZ may have some problems paying its short term obligations.
OZ has a worse Quick ratio (0.88) than 70.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
OZ Yearly Current Assets VS Current LiabilitesOZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

OZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.31%.
The Revenue has grown by 18.68% in the past year. This is quite good.
Measured over the past years, OZ shows a very strong growth in Revenue. The Revenue has been growing by 38.96% on average per year.
EPS 1Y (TTM)-62.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.45%
Revenue 1Y (TTM)18.68%
Revenue growth 3Y38.96%
Revenue growth 5YN/A
Sales Q2Q%114.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OZ Yearly Revenue VS EstimatesOZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OZ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OZ Price Earnings VS Forward Price EarningsOZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OZ Per share dataOZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELPOINTE PREP LLC

NYSEARCA:OZ (4/24/2025, 8:04:02 PM)

61.655

+0.41 (+0.66%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners38.22%
Inst Owner Change-0.35%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap232.44M
Analysts0
Price TargetN/A
Short Float %1.82%
Short Ratio4.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 86.89
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-6.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-40.19
FCFYN/A
OCF(TTM)-3.63
OCFYN/A
SpS0.71
BVpS80.05
TBVpS80.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.61%
ROE -7.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.51%
ROA(5y)-2.35%
ROE(3y)-4.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2499.91%
Cap/Sales 5153.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z N/A
F-Score2
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)4896.45%
Cap/Depr(5y)18197.1%
Cap/Sales(3y)5462.86%
Cap/Sales(5y)10108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.68%
Revenue growth 3Y38.96%
Revenue growth 5YN/A
Sales Q2Q%114.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.11%
OCF growth 3YN/A
OCF growth 5YN/A